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Abstract
Background—Abnormal host-microbe interactions are implicated in the pathogenesis of
inflammatory bowel diseases. Previous 16S rRNA sequence analysis of intestinal tissues
demonstrated that a subset of Crohn’s disease (CD) and ulcerative colitis (UC) samples exhibited
altered intestinal associated microbial compositions characterized by depletion of Bacteroidetes
and Firmicutes (particularly Clostridium taxa). We hypothesize that NOD2 and ATG16L1 risk
alleles may be associated with these alterations.
Methods—To test this hypothesis, we genotyped 178 specimens collected from 35 CD, 35 UC
and 54 control patients for the three major NOD2 risk alleles (Leu 1007fs, R702W and G908R)
and the ATG16L1T300A risk allele, that had undergone previous 16S rRNA sequence analysis.
Our statistical models incorporated the following independent variables:1.) disease phenotype
(CD, UC, Non-IBD Control); 2.) NOD2 composite genotype (NOD2R = at least one risk allele,
NOD2NR = no risk alleles); 3.) ATG16L1T300A genotype (ATG16L1R/R, ATG16L1R/NR,
ATG16L1NR/NR); 4.) patient age at time of surgery and all first order interactions. The dependent
variable(s) were the relative frequencies of bacterial taxa classified by applying the RDP 2.1
classifier to previously reported 16S rRNA sequence data.
Results—Disease phenotype, NOD2 composite genotype and ATG16L1 genotype were
significantly associated with shifts in microbial compositions by nonparametric MANCOVA.
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Shifts in the relative frequencies of Faecalibacterium and Escherichia taxa were significantly
associated with disease phenotype by nonparametric ANCOVA.
Conclusions—These results support the concept that disease phenotype and genotype are
associated with compositional changes in intestinal associated microbiota.
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INTRODUCTION
The inflammatory bowel diseases (IBD) represent a heterogeneous spectrum of chronic
inflammatory disorders of the digestive tract [1, 2]. Crohn’s disease (CD) and ulcerative
colitis (UC) represent the two major IBD phenotypes. CD can affect any segment of the
intestinal tract, often in a discontinuous fashion, but most commonly affects the distal ileum
and colon. UC is confined within the colon, where disease extends proximally from the
rectum in a continuous fashion.
Abnormal interactions between host and microbes (either pathogen or commensal) are
implicated in the pathogenesis of IBD [3–8]. Studies of experimental animal models reveal
that intestinal inflammation is not observed in germ-free mice. Antibiotics or diversion of
fecal flow can reduce inflammation in experimental animal models and in humans in clinical
settings. Moreover, both CD and UC are associated with significant shifts in the composition
of the enteric microbiota (i.e., dysbiosis), most notably, depletion of the phyla Bacteroidetes
and Firmicutes, compared to control patients [3–8]. For instance, we observed that the
abundances of Bacteroidetes and Firmicutes were reduced 10–100 fold in surgically resected
tissues collected from a subset of IBD patients, compared with control (non-IBD) patients
[8]. The loss of Firmicutes was due primarily to reduction in the abundances of species that
belong to the bacterial order clostridiales, particularly members of Clostridium clusters
XIVa and IV [8,9].
Greater than forty inflammatory bowel disease susceptibility loci have been identified in the
past 10 years through linkage analysis, association mapping, and candidate gene association
studies [1, 10–18]. Risk alleles of two genes, NOD2 and ATG16L1, have been linked to
ileal CD, a subphenotype of IBD, and to abnormalities in Paneth cell function [14,15,18].
Paneth cells are specialized small intestinal lining cells, with the highest concentration in the
ileum, that secrete antimicrobial peptides and proteins, and thus potentially play an
important role in host containment of lumenal bacteria. Disruption of normal Paneth cell
function could therefore impact the composition and abundance of the intestinal microbiota,
as has been observed in IBD. In order to test the hypothesis that human genetic factors are
associated with shifts in microbial populations previously observed in a subset of
inflammatory bowel disease intestinal samples [8], we genotyped these samples for the three
major NOD2 (Leu1007fs, R702W, G908R) alleles and the ATG16L1T300A allele.
MATERIALS AND METHODS
Patients and acquisition of samples
This study was approved by the Institutional Review Boards of Washington University-St.
Louis and Stony Brook University. The 178 de-identified intestinal tissue DNA samples
were prepared as previously described from surgically resected tissues collected from 35 CD
(both ileal and non-ileal CD), 35 UC and 54 control patients at the Mount Sinai School of
Medicine under a protocol that was approved by the Institutional Review Boards of Mount
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Sinai Hospital and the University of Colorado [8]. These samples were linked to de-
identified information on patient age at the time of surgery and disease phenotype. The
diagnosis of CD or UC was established on the basis of gross and microscopic pathological
features [8].
Genotyping of NOD2 and ATG16L1 SNPs
Genotyping of the three predominant NOD2 single nucleotide polymorphisms
(SNPs),Leu1007fsInsC (rs2066847, SNP13), R702W (rs2066844, SNP8) and G908R
(rs2066845, SNP12), and the ATG16L1T300A (rs2241880) SNP was conducted using the
Sequenom MassArray System (Sequenom Inc., San Diego, CA) and/or the Taqman MGB
(Applied Biosystems, Foster City, CA) genotyping platform according to the manufacturer’s
recommendations [19]. For statistical analyses, risk alleles were combined into pooled
genotypes. Thus, the NOD2 genotype categories were: 1.) no NOD2 risk alleles (NR/NR);
2.) one NOD2 risk allele (R/NR); and 3.) two NOD2 risk alleles (R/R). Similarly, the
ATG16L1 genotype categories were 1.) no ATG16L1 risk allele (NR/NR); 2.) one
ATG16L1 risk allele (R/NR);and 3.) two ATG16L1 risk allele (R/R).
Statistical analysis
The bacterial rRNA sequences (depth of ～80/sample) of the intestinal samples have been
previously reported [8]. The previous phylogenetic classification of rRNA sequences was
confirmed using the Naïve Bayesian Classifier of the Ribosome Database Project (Version
2.1, http://sourceforge.net/projects/rdp-classifier/) [20,21]. The taxa were binned at the phyla
level: 1. Actinomycetes; 2. Bacteroidetes; 3. Firmicutes; 4. Proteobacteria; 5. Other phyla.
The Firmicutes clade was further subdivided into the following five subcategories, based on
concordance between the RDP classifier and the Greengenes 16S rRNA phylogenetic
schema [8,20–22]: 3A. Firmicutes/Clostridium Group XIVa, 3B. Firmicutes/Clostridium
Group IV, 3C. Firmicutes/Clostridium/ Other, 3D. Firmicutes/Bacillus, and 3E. Firmicutes/
Other classes. The relative frequencies of each of the eight categories were subjected to logit
transformation: log2{(x+0.01)/[100-(x+0.01)]}, where x is the relative frequency (%). The
effect of clinical phenotype (CD, UC, Control), NOD2 genotype (NR/NR, R/NR, R/
R),ATG16L1 genotype (NR/NR, R/NR, R/R), and patient age on these eight categories was
analyzed by nonparametric multivariate analysis of covariance (MANCOVA) [23,24] using
the R software package (Version 2.8.1). The purpose of the logit transformation was to
expand the original relative frequency values (0–100%) to the real space, in which the term
0.01 was added to avoid infinite value during the transformation. The effect of these
independent variables on lower taxonomic ranks was analyzed by nonparametric analysis of
covariance (ANCOVA) [23,24].
UniFrac tests [25] were performed using the web-service provided at http://
bmf.colorado.edu/unifrac. The phylogenetic tree tested in this analysis was constructed by
neighbour joining of sequences representative of 95% operational taxonomic units (OTUs;
assembled through the application sortx [26], followed by parsimony insertion of remaining
sequences, by use of the ARB software package [26]. UniFrac significance and
environmental clustering was ascertained by 100 jackknife re-samplings using normalized,
weighted UniFrac. Dendrograms were constructed from UniFrac scores through Unweighted
Pair Group Method with Arithmetic (UPGMA) mean clustering.
RESULTS
The distribution of NOD2 and ATG16L1 genotypes in 178 tissue samples are shown in
Table 1. Because some combinations of NOD2, ATG16L1, and disease phenotype were not
sampled in this study, we collapsed the NOD2 genotypes into two categories: NOD2R
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(harboring at least one of the three major NOD2 risk alleles) and NOD2NR (harboring none
of the three major risk alleles). We retained the three ATG16L1T300A genotype categories:
R/R, R/NR, and NR/NR. In our statistical model we incorporated the three disease
phenotypes: 1.) CD and 2.) UC and 3.) Control non-IBD samples (collected predominantly
from cancer patients; [8]). As previously reported [8], the CD and UC patients were
significantly younger at the time of surgery than the control patients.
The previously reported 16S sequencing data for these 178 specimens [8] were reclassified
using the recently released Ribosomal Database Project (RDP) 2.1 classifier [20,21]. This
software assigned >98% of the sequences to one of four phyla: Actinobacteria,
Bacteroidoetes, Firmicutes and Proteobacteria. The Firmicutes clade was further divided to
correspond to Clostridium Group XIVa and IV groups [8, 9,20,21]. As shown in Table 2, the
relative frequencies of Clostridium Group XIVa and Clostridium Group IV taxa were
significantly decreased in CD compared to Control samples, and the relative frequencies of
Actinobacteria and Proteobacteria taxa were significantly increased. Nonparametric
MANCOVA analysis of the effect of clinical phenotype, NOD2 composite genotype,
ATG16L1 genotype, and age of surgery on intestinal (ileum and colon) microbial
composition, as defined by the relative frequencies of 8 bacterial categories (excluding
Other Phyla), revealed that clinical phenotype, NOD2 composite genotype, and ATG16L1
genotype were associated with shifts in microbial composition (Table 3).
To determine whether particular lower-level taxonomic groups (i.e., sub-phylum) were
associated with clinical phenotypes or risk alleles, nonparametric ANCOVA analyses were
conducted on individual genera within Clostridial clusters XIVa (e.g., Lachnospiracea) and
IV (e.g., Ruminococcaceae). Indeed, the relative abundances of several clostridial genera
were associated with disease phenotype, NOD2 composite genotype, and/or ATG16L1
genotype (Table 4). Within the phylum Proteobacteria, only the genus Escherichia was
significantly populated in all the specimens (See Table 4). Association between disease
phenotype and shifts in the Faecalibacterium and the Escherichia remained significant after
applying the Bonferroni correction for multiple comparisons (n=11).
The aforementioned statistical modeling analyzed the relative abundances of sequence
relatedness groups (operational taxonomic units) that were assembled on the basis of
taxonomic sequence classification. Phylum and sub-phylum level sequence classifications
using the Naïve Bayesian classifier were nearly identical to our previously reported
groupings. Thus the reported statistical associations between clinical phenotypes, risk allele
genotypes, and intestinal microbiotas are robust to particular schemes of OTU classification.
Nevertheless, we sought to provide a non-OTU-based assessment of these results through
comparison of phylogenetic community structure.
In general, analysis of microbial communities using the UniFrac metric [25] corroborated
the findings that ATG16L1 and NOD2 risk alleles are associated with altered microbiotas.
To mask potential confounding by disease phenotype, we first compared the microbiotas of
IBD patients as a function of ATG16L1 and NOD2 risk alleles taken independently (Fig. 1A
and 1C). In the case of each gene, the microbiotas of NR/NR, NR/R, and R/R subjects
differed significantly from one another (P < 0.03 for each pairwise comparison). Distance-
based clustering of microbiotas indicated that the microbiotas of NR/NR and NR/R
individuals were more similar to one another than either one were to R/R subjects (Jackknife
support ≥ 90%). Thus, an allele-dosage effect on the intestinal microbiotas was apparent in
the analyses of both ATG16L1 and NOD2. R/R IBD subjects also were observed to be
outliers when non-IBD controls were included in the analysis (Fig. 1B and 1D).
Interestingly, for ATG16L1, non-IBD microbiotas were observed to cluster to the exclusion
of IBD microbiotas, indicating that disease phenotype (IBD vs. Non-IBD) was a critical
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modifier of the microbiota. In contrast, NOD2 genotypes tended to cluster together,
regardless of disease phenotype (none of the Non-IBD control subjects had a NOD2 R/R
genotype). However, none of the pair-wise comparisons of genotype/phenotype categories
was statistically significant when P-values were corrected for multiple comparisons.
DISCUSSION
The objective of this study was to determine whether human genetic factors underlie shifts
in microbial populations that have been observed in a subset of CD and UC patients [8]. We
focused on NOD2 and ATG16L1 risk alleles, which are associated with abnormal Paneth
cell function. The NOD2 gene is constitutively expressed in human Paneth cells [14], which
are specialized intestinal cells that secrete antimicrobial peptides and proteins into intestinal
crypts. In one study [15], reduced α-defensin expression was associated with NOD2 risk
alleles. Although the ATG16L1 gene is expressed in multiple cell lineages, the ATG16L1
risk allele has been associated with abnormalities in both mice and human Paneth cells [18].
We reason that alterations in Paneth cell function can perturb host containment of lumenal
bacteria, particularly in the ileum where Paneth cells are most abundant [28]. This concept
has been supported by the finding that genetic mouse models with altered secretion of
enteric defensins from Paneth cells exhibit alterations in small intestinal microbial
composition [29].
Analysis of the effect of NOD2 and ATG16L1 risk alleles on the intestinal microbiota is
complicated by established associations between the NOD2 and ATG16L1 risk alleles with
disease subphenotype (ileal CD but not Crohn’s colitis) and earlier age of surgery. For this
reason, all of these variables were included in the multivariate analyses. We confirmed that
decreases in the relative frequencies of Clostridial XIVa and IV taxa and increases in
Proteobacteria taxa were observed in CD specimens compared to control specimens [3,7,8].
Our results support the hypothesis that both genetic factors and disease phenotype are
associated with significant shifts in microbial populations.
Analysis of bacterial genera within the phyla Firmicutes and Proteobacteria confirmed
previous results linking shifts in Faecalibacterium and Escherichia with disease phenotype
[30,31]. Inspection of the data also suggests that shifts in the relative frequencies of several
genera may be associated with NOD2 and/or ATG16L1 genotype, but these results did not
reach significance after correction for multiple comparisons. However given the shallow
level of DNA sequence coverage in this dataset, which resulted in low observed sequence
abundances for most genera, it is likely that analyses of individual genera were
underpowered. Studies of monozygotic twins that were either discordant or concordant for
CD have shown that changes in microbial composition are associated with development of
ileal CD subphenotype [31]. Thus the observed shifts in microbial populations could
potentially reflect simply the presence of ileal CD.
The 178 specimens analyzed in this study were heterogeneous with respect to CD
subphenotypes because ileal CD and Crohn’s colitis patients were not differentiated in this
study. Specimens were collected from both the ileum and colon, and included samples of
both grossly disease unaffected and affected regions of the intestine (gross pathology was
not significantly associated with alterations in microbial populations in our initial study;
[8]). Furthermore, because surgical histories were not recorded, the contribution of previous
surgeries (e.g. previous ileocolic resections) to shifts in microbial composition cannot be
evaluated in this study. Further analysis of the contribution of ATG16L1 risk allele and
other CD risk alleles to shifts in mucosal associated microbiota as it relates to IBD
pathogenesis, will require comprehensive analysis of additional patient samples with
detailed annotation of disease phenotype (including CD subphenotypes), history of previous
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surgeries, genotype, anatomic location, pathology (restrict to disease unaffected regions), as
well as more extensive analysis of other microbiota subsets.
Despite potential confounding variables, the results of this study strongly suggest that
specific genetic loci implicated in human disease can impact the composition of the
intestinal microbiota. Although imbalances in commensal microbiota have been associated
with many human disease states (CD, obesity, antibiotic-associated diarrhea, prostatitis), the
causal relationships between disease and dysbiosis remain unclear in most cases. However,
our observation that shifts in microbial populations are associated with particular CD risk
alleles indicates that dysbiosis is not simply a consequence of a chronic disease and its
attendant, long-term treatment. Additional experimental and clinical studies are necessary to
determine whether and how altered commensal populations contribute to disease
progression and resolution.
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UniFrac analysis of CD risk alleles and enteric microbiota. The images show the results of
UPGMA clustering of environments (A). ATG16L1 genotype in IBD patients (B). NOD2
genotype in IBD patients (C). ATG16L1 genotype in IBD and non-IBD control patients (D).
NOD2 genotype in IBD and non-IBD control patients based on the UniFrac metric.24
Jackknife resampling (100 replicates) was performed to assess the statistical support for the
topology of each tree. Nodes with high support are indicated by the fraction of trees in
which the nodes were recovered (>50%: >50% to <70%; >70%: >70% to <90%; >90%:
>90% to 100%).
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Table 1







NOD2R/R ATG16L1R/R 0.0% 3.4% 1.7%
NOD2R/R ATG16L1R/NR 4.9% 0.0% 0.0%
NOD2R/R ATG16L1NR/NR 3.3% 0.0% 0.0%
NOD2R/NR ATG16L1R/R 24.6% 0.0% 6.8%
NOD2R/NR ATG16L1R/NR 8.2% 10.3% 3.4%
NOD2R/NR ATG16L1NR/NR 3.3% 0.0% 3.4%
NOD2NR/NR ATG16L1R/R 16.4% 20.7% 20.3%
NOD2NR/NR ATG16L1R/NR 23.0% 34.5% 28.8%
NOD2NR/NR ATG16L1NR/NR 16.4% 31.0% 35.6%
Median age years (range) 40y (18–68) 40y (19–69) 64y (25–89)
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Table 2







Actinobacteria 6.8 ± 13.3* 5.7 ± 7.7 3.7 ± 8.1
Bacteroidetes 19.1 ± 21.4 21.8 ± 23.6 26.1 ± 23.1
Firmicutes/Clostridium Group XIVa 11.1 ± 15* 17.9 ± 20.3 22.9 ± 21.6
Firmicutes/Clostridium Group IV 4.5 ± 9.8* 6.3 ± 8.8 9.7 ± 11.9
Firmicutes/Clostridium/ Other genera 5.6 ± 17.4 5.0 ± 7.6 6.1 ± 10.5
Firmicutes/Bacilli 21.0 ± 22.2 18.9 ± 24.8 19.9 ± 30.0
Firmicutes/Other classes 0.1 ± 0.3 0.2 ± 0.5 0.7 ± 2.9
Proteobacteria 31 ± 27.8* 23.1 ± 25.0 9.5 ± 19.0
Other phyla 0.9 ± 2.9 1.3 ± 4.9 1.5 ± 5.7
The * indicates the taxa that have significantly different relative frequencies in CD compared to Control samples via the Wilcoxon rank sum tests at
the familywise error rate of 0.05 (2-tailed) with the Bonferroni correction for multiple comparisons, n = 9.
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Non-parametric MANCOVA results.
Source DF F value Pr > F
Disease phenotype 2,158 5.532 0.002 *
NOD2 (composite) genotype 1,158 2.756 0.024 *
ATG16L1 genotype 2,158 2.637 0.011 *
Age 1,158 2.173 0.055
NOD2 genotype : disease phenotype 2,158 1.057 0.36
NOD2 genotype : ATG16L1 genotype 2,158 0.795 0.603
NOD2 genotype : age 1,158 6.579 0.001*
ATG16L1 genotype : disease phenotype 4,158 1.693 0.052
ATG16L1 genotype : age 2,158 1.782 0.077
Disease phenotype : age 2,158 1.019 0.385
The asterisk (*) denotes significant P values (<0.05).
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  Coprococcus 0.011 0.127 0.043 0.251
  Dorea 0.024 0.025 0.087 0.428
  Roseburia 0.013 0.928 0.157 0.586
  Syntrophococcus 0.103 0.809 0.034 0.913
“Firmicutes”/”Clostridia” Clostridiales”/“Ruminococcaceae”
  Anaerotruncus 0.387 0.899 0.015 0.471
  Butyricicoccus 0.006 0.807 0.138 0.79
  Faecalibacterium 0.001* 0.523 0.018 0.363
  Oscilibacter 0.028 0.069 0.176 0.096
  Ruminococcus 0.042 0.946 0.187 0.253
  Subdoligranulum 0.087 0.083 0.007 0.298
“Proteobacteria”/Gamma proteobacteria/“Enterobacteriales”/Enterobacteriaceae
  Escherichia 0.001* 0.96 0.397 0.013
The uncorrected P values for each independent variable is shown. The asterisk (*) denotes significant P values at the familywise error rate of 0.05
after multiple tests correction (number of tests = the number of genera included in the table = 11).
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